Clinical Guest Contributors

  1. Ossium's Unconventional Site Strategy For Studying A Novel Bone Marrow Donor Source 10/23/2026

    Ossium CEO Kevin Caldwell explains how an unconventional multisite Phase 1 trial is shaping the company's novel bone marrow product’s path ahead.

  2. Who Owns Your Clinical Trial Software When The Vendor Leaves? 10/22/2026

    When a clinical trial software vendor exits, sponsors still own the risk. Learn what to secure before signing a contract to protect data, validation, and continuity.

  3. Beyond RAG: Why Life Sciences AI Workflows Need Better Context, Not Just Better Models 10/21/2026

    Teams want AI systems that can answer complex scientific questions across value chain, but as these systems move closer to production, a recurring problem is becoming visible.

  4. What The New PDUFA Guidance Means For Drug Development 10/21/2026

    Learn how the FDA’s updated PDUFA meeting guidance affects sponsor engagement, preparation, and the way feedback shapes drug development.

  5. The Site Landscape Is Evolving, But How? Tufts CSDD Shares New Findings 10/20/2026

    Tufts CSDD data reveals how academic, independent, and network-affiliated clinical trial sites differ in growth, reach, staffing, and performance.

  6. Testing Early Treatment In Head And Neck Cancer Without Compromising Curative Care 10/20/2026

    Can early APG-157 treatment control head and neck cancer without delaying curative care? A Phase 3 trial puts timing, safety, and outcomes to the test.

  7. The New Clinical Trial Regulatory Landscape Balances Speed, Quality, and Compliance — Are You Ready? 10/19/2026

    Part one of this two-part series explores how clinical trial regulation aims to balance speed, quality, compliance, and digital innovation.

  8. Get Ready For Regulators With This Speed-Quality-Compliance Framework 10/19/2026

    Part two of a two-part series, experts Sapna Rani and Shaun Hastings offer a five-part framework to balance speed, quality, and compliance amid evolving clinical trial regulations.

  9. The U.S. Clinical Trial Recruiting Pipeline – September 2026 10/16/2026

    This WhichTrial report breaks down which drug trials are growing the most and the least, drugs that are no longer being studied, and new drugs to the clinic from August to September.

  10. Can Psychedelic‑Assisted Treatment Redefine Emotional Care In Oncology? 10/16/2026

    Psychedelic-assisted treatment may offer faster, lasting relief for cancer patients facing adjustment disorder, depression, and anxiety.